Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases. [electronic resource]
- Clinical genitourinary cancer Dec 2006
- 232-4 p. digital
Publication Type: Case Reports; Journal Article
1558-7673
10.3816/CGC.2006.n.042 doi
Aged Aged, 80 and over Antineoplastic Agents--therapeutic use Carcinoma, Renal Cell--pathology Combined Modality Therapy Disease-Free Survival Humans Indoles--therapeutic use Interferon-alpha--therapeutic use Interleukin-2--therapeutic use Kidney Neoplasms--pathology Male Neoplasm Metastasis Nephrectomy Pyrroles--therapeutic use Sunitinib